These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37046198)

  • 1. Effects of Alkoxy Chain Length and 1-Hydroxy Group on Anticolorectal Cancer Activity of 2-Bromoalkoxyanthraquinones.
    Mekzali NW; Chee CW; Abdullah I; Lee YK; Rashid NN; Lee VS; Othman R; Hashim NM; Chee CF
    Med Chem; 2023; 19(9):897-905. PubMed ID: 37046198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
    Islam MS; Ghawas HM; El-Senduny FF; Al-Majid AM; Elshaier YAMM; Badria FA; Barakat A
    Bioorg Chem; 2019 Feb; 82():423-430. PubMed ID: 30508794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy.
    Patrício RPS; Videira PA; Pereira F
    Bioorg Med Chem; 2022 Jan; 53():116530. PubMed ID: 34861473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic Evaluation and Molecular Docking Studies of Aminopyridine Derivatives as Potential Anticancer Agents.
    Ilyas U; Alkury LT; Naaz S; Muhammad SA; Nadeem H; Altaf R; Zaman SU; Faheem M; Sajid I; Cheema MT; Mannan A; Shah FA; Li S
    Anticancer Agents Med Chem; 2022; 22(14):2599-2606. PubMed ID: 34963435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines.
    Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y
    Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Activity of Electron-Deficient Metal Complexes against Colorectal Cancer in vitro Models.
    Azmanova M; Soldevila-Barreda J; Bani Hani H; Lord RM; Pitto-Barry A; Picksley SM; Barry NPE
    ChemMedChem; 2019 Nov; 14(22):1887-1893. PubMed ID: 31545555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study.
    Tantawy MA; El-Sherbeeny NA; Helmi N; Alazragi R; Salem N; Elaidy SM
    Mol Cell Biochem; 2020 Jun; 469(1-2):143-157. PubMed ID: 32356241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
    Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
    ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment.
    Ciftci H; Sever B; Ocak F; Bayrak N; Yıldız M; Yıldırım H; DeMirci H; Tateishi H; Otsuka M; Fujita M; TuYuN AF
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating Pluripotency Network Genes with Omega-3 DHA is followed by Caspase- 3 Activation and Apoptosis in DNA Mismatch Repair-Deficient/KRAS-Mutant Colorectal Cancer Stem-Like Cells.
    Mahmoudi N; Delirezh N; Sam MR
    Anticancer Agents Med Chem; 2020; 20(10):1221-1232. PubMed ID: 32116204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
    Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
    Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines.
    Sheikh BY; Sarker MMR; Kamarudin MNA; Mohan G
    Biomed Pharmacother; 2017 Dec; 96():834-846. PubMed ID: 29078261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents.
    Li BH; Ge JQ; Wang YL; Wang LJ; Zhang Q; Bian C
    Comput Math Methods Med; 2021; 2021():3195957. PubMed ID: 34413896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
    Alam MS; Lee DU
    Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones.
    Toan DN; Thanh ND; Truong MX; Van DT
    Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles.
    Mokenapelli S; Thalari G; Vadiyaala N; Yerrabelli JR; Irlapati VK; Gorityala N; Sagurthi SR; Chitneni PR
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000006. PubMed ID: 32309890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction.
    Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L
    Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.